Hepatitis C (HCV)

A liver disease caused by the Hepatitis C virus and is primarily transmitted through blood-to-blood contact
Participate Today

Eligible individuals diagnosed with Hepatitis C will receive either Bemnifosbuvir-Ruzasvir, the investigational medication being studied, or Sofosbuvir-Velpatasvir, an FDA-approved treatment. Treatment will be provided completely free of charge—there is no cost to you or your insurance.

You may be COMPENSATED for your time. All visits are at no cost to you or your insurance.We prioritize your confidentiality and handle protected health information (PHI) to ensure patient privacy and compliance with HIPAA regulations. We will not share your personal information.

Benefits of Participation Include:

  • Compensation for time and travel
  • Medical care (physical exams, lab work) at no cost to you or your insurance
  • Access to Bemnifosbuvir-Ruzasvir or Sofosbuvir-Velpatasvir at no cost to you or your insurance
Participate Today
Learn More
Fill out an interest form and we will give you a call with more information.

Please select at least one option.
Please select at least one option.
There was an error submitting the form. Try fixing the error or submitting again.

Individuals who have been diagnosed with celiac disease still have occasional symptoms such as abdominal pain, abdominal cramping, bloating, and gas, despite being on a gluten-free diet. If you have celiac disease and experience some of these symptoms periodically, this might be a good study for you.

You may be COMPENSATED for your time. All visits are at no cost to you or your insurance.

We prioritize your confidentiality and handle protected health information (PHI) to ensure patient privacy and compliance with HIPAA regulations. We will not share your personal information.

Benefits of participation include:

  • Compensation for time and travel
  • Medical care (physical exams, lab work, EGDs) at no cost to you or your insurance
  • Gain access to cuttting edge therapies

Participate Today